Companies / Abeona Therapeutics Inc.
Abeona Therapeutics Inc.
Nasdaq: ABEOCIK 318306CLEVELAND, OH
Insider flow · last 90 daysNet sells $35.5K
Financials · FY2025
Ownership
57.2M shares outstanding · as of Aug 10, 2026
Ownership
| Insiders | 6.76% | 3,866,387 |
| 10%+ / strategic | 10.57% | 6,043,629 |
| Institutions | 73.40% | 41,971,959 |
| Public float | 9.27% | 5,302,042 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 12
View all →| Insider | % of shares | Shares |
|---|---|---|
Seshadri VishwasCEOChief Executive Officer · Director | 2.50% | 1,430,423 |
Vazzano Joseph WalterChief Financial Officer | 0.99% | 567,775 |
O'Malley Brendan M.SVP, Chief Legal Officer | 0.79% | 451,134 |
Vasanthavada MadhavChief Commercial Officer | 0.56% | 318,619 |
Amoroso MichaelDirector | 0.38% | 217,779 |
Charles Faith L.Director | 0.31% | 176,407 |
Alland LeilaDirector | 0.30% | 173,614 |
Wuchterl Donald A.Director | 0.29% | 167,935 |
Silverstein Christine BerniDirector | 0.24% | 137,722 |
Zeiher Bernhardt GDirector | 0.15% | 84,458 |
Institutional holders 109
View all →| Holder | Value | % of shares |
|---|---|---|
| $26.16M | 8.68% | |
| $20.72M | 5.86% | |
| $18.46M | 5.22% | |
| $14.53M | 4.82% | |
| $14.10M | 4.68% | |
| $13.18M | 4.37% | |
| $10.22M | 2.89% | |
| $9.71M | 3.22% | |
| $6.43M | 1.82% | |
| $5.53M | 1.84% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | OneDigital Investment Advisors LLC 13F manager | New | Common stock | $10.22M | +1.7M | 1,653,024 2.89% of shares | medium |
| Q2 2026 as of | AIGH Capital Management LLC 13F manager | Add | Common stock | $6.10M | +987K +49.35% | 2,987,000 5.22% of shares | medium |
| Q1 2026 as of | Tang Capital Management, LLC 13F manager | Trim | Common stock | $-2.69M | -600K -60.00% | 400,000 0.70% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Trim | Common stock | $-2.14M | -405K -44.39% | 507,625 0.89% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $1.19M | +193K +6.10% | 3,352,474 5.86% of shares | low |
| Q1 2026 as of | Knoll Capital Management, LLC 13F manager | Add | Common stock | $1.12M | +250K +105.77% | 485,515 0.85% of shares | low |
| Q4 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-1.01M | -202K -54.28% | 169,732 0.30% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common stock | $969.0K | +216K | 216,305 0.38% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Adage Capital Management, L.P. | Passive13G/A | — |
| Daniel Kaufman | Passive13G | — |
| Orin Hirschman | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ABEO | — | 00289Y206 |